Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Lluís

Lluís Magí I Carceller, Girona ES

Patent application numberDescriptionPublished
20110200248Method and system for aligning three-dimensional surfaces - A method for associating a three-dimensional surface representing a real object and a three-dimensional reference surface, said reference surface being represented by a set of reference points, the method comprising: obtaining a set of real points representing the real surface, determining the normal vector of each point of said obtained set of real points, selecting, among the set of real points, control points according to the determined normal vector by converting the set of real points to a bi-dimensional space of normal vectors, generating sets of points having similar normal vector among the points of the set of real points and selecting, for each set of points with similar normal vector, one point that is a control point of the real surface, determining correspondence points close to the set of reference points that are determined to correspond to the control points of the real surface, and determining the motion that minimizes the distances between the control points of the real surface and the correspondence points.08-18-2011

Lluís Puigdemont Camos, Girona ES

Patent application numberDescriptionPublished
20100295892METHOD OF CLEANING A SCRAPER DEVICE - The invention relates to a method of cleaning doctor devices (11-25-2010

Lluís Puigdemont Camos, Girona ES

Patent application numberDescriptionPublished
20100295892METHOD OF CLEANING A SCRAPER DEVICE - The invention relates to a method of cleaning doctor devices (11-25-2010

Lluís Ribas De Pouplana, Barcelona ES

Patent application numberDescriptionPublished
20090291465Screening Method for Identifying New Drugs - A screening method for identifying new drugs A screening method for identifying a candidate to drug wherein said method 5 comprises the following steps: a) obtaining an expression vector which comprises a gene sequence codifying a naturally occurring pathogenic non-discriminating tRNA synthetase; b) transforming isolated mammalian cells with the expression vector; c) growing the recombinant cells resulting from (b) in a nutrient medium under conditions which allow the expression of the 10 pathogenic tRNA synthetase, resulting the expression of the pathogenic tRNA synthetase into cell death or a decrease in the rate of cell division; d) providing a substance to be tested; and e) analyzing the resulting cell growth, wherein if there is an increase in cell growth, then the substance selectively inhibits the activity of the pathogenic tRNA synthetase and does 15 not affect to its cellular ortholog, resulting that said substance is a candidate to drug.11-26-2009